Zobrazeno 1 - 10
of 343
pro vyhledávání: '"G R Peters"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:1944-1948
The pharmacokinetics and dose proportionality of cefmetazole were studied in 24 healthy volunteers (12 young and 12 elderly). Each volunteer received single 0.5-, 1-, and 2-g doses of cefmetazole administered intravenously over 5 min according to a t
Publikováno v:
Biopharmaceuticsdrug disposition. 19(2)
Tirilazad is a membrane lipid peroxidation inhibitor being studied for the management of subarachnoid hemorrhage; phenytoin is used for seizure prophylaxis in the same disorder. The induction of tirilazad clearance by phenytoin was assessed in 12 vol
Autor:
J C, Fleishaker, G R, Peters
Publikováno v:
International journal of clinical pharmacology and therapeutics. 35(1)
The dose proportionality of tirilazad pharmacokinetics at dosages above 6.0 mg/kg/day were assessed in 18 healthy male volunteers between the ages of 19 and 46 years. Subjects were randomized to receive either 1.5 mg/kg, 3.0 mg/kg, or 4.0 mg/kg tiril
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(2)
The effect of ketoconazole, a CYP3A inhibitor, on the oral bioavailability of tirilazad mesylate was assessed in 12 healthy subjects, who received the following treatments in a crossover design: a) 10 mg/kg tirilazad mesylate solution orally on the f
Publikováno v:
International journal of clinical pharmacology and therapeutics. 32(5)
Multiple dose pharmacokinetics and tolerability of tirilazad mesylate were assessed at the maximum dosage and duration expected for tirilazad mesylate therapy of subarachnoid hemorrhage and head injury. Healthy male subjects (47) received either 1 mg
Publikováno v:
Pharmaceutical research. 11(2)
Autor:
W J, Aseltyne, G R, Peters
Publikováno v:
Topics in health care financing. 20(3)
This chapter discusses tax exemption of integrated delivery systems, including the requirements for exemption, the charitable purposes test, the private inurement and private benefit tests, and an application to integrated delivery systems. It also d
Autor:
G R, Peters
Publikováno v:
Topics in health care financing. 20(3)
This chapter discusses the nature of an integrated system, the reasons for developing an integrated delivery system, and various organizational structures that might be used. The chapter then identifies several of the critical business issues affecti
Autor:
G R, Peters
Publikováno v:
Healthcare financial management : journal of the Healthcare Financial Management Association. 45(12)
Hospitals trying for successful business cooperation with physicians have become frustrated with risky joint ventures, quick-fix recruiting plans, and management service organizations. An integrated delivery system (IDS), however, may succeed where o
Autor:
G R, Peters
Publikováno v:
Healthcare financial management : journal of the Healthcare Financial Management Association. 45(11)
Traditional methods for cooperation among hospitals and physicians have not been successful at warding off problems that prompt hospitals and physicians to work together in the first place. Management service organizations and income guarantees have